KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Incyte (INCY) Return on Sales (2016 - 2026)

Incyte filings provide 17 years of Return on Sales readings, the most recent being 0.24% for Q1 2026.

  • For the quarter ending Q1 2026, Return on Sales rose 9.0% year-over-year to 0.24%, compared with a TTM value of 0.27% through Mar 2026, up 26.0%, and an annual FY2025 reading of 0.25%, up 24.0% over the prior year.
  • Return on Sales hit 0.24% in Q1 2026 for Incyte, up from 0.2% in the prior quarter.
  • The five-year high for Return on Sales was 0.33% in Q2 2025, with the low at 0.43% in Q2 2024.
  • Median Return on Sales over the past 5 years was 0.18% (2022), compared with a mean of 0.13%.
  • The sharpest move saw Return on Sales plummeted -64bps in 2024, then skyrocketed 76bps in 2025.
  • Year by year, Return on Sales stood at 0.03% in 2022, then soared by 546bps to 0.2% in 2023, then dropped by -14bps to 0.17% in 2024, then grew by 16bps to 0.2% in 2025, then increased by 20bps to 0.24% in 2026.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.24%, 0.2%, and 0.31% for Q1 2026, Q4 2025, and Q3 2025 respectively.